Previous 10 | Next 10 |
Image source: The Motley Fool. AngioDynamics (NASDAQ: ANGO) Q3 2020 Earnings Call Apr 07, 2020 , 8:00 a.m. ET Operator Continue reading
AngioDynamics, Inc. (ANGO) Q3 2020 Results Earnings Conference Call April 7, 2020 8:00 AM ET Company Participants Jim Clemmer - President & CEO Steve Trowbridge - EVP & CFO Conference Call Participants Jayson Bedford - Raymond James Jason Mills - Canaccord Genuity...
The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2020 Q3 earnings Read more ...
AngioDynamics ( ANGO +6.2% ) Q3 results : More news on: AngioDynamics, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
AngioDynamics (NASDAQ: ANGO ): Q3 Non-GAAP EPS of $0.01 beats by $0.04 ; GAAP EPS of -$0.15 misses by $0.01 . More news on: AngioDynamics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Fiscal 2020 Third Quarter Highlights Net sales of $69.8 million increased 6.5% compared to the prior-year quarter Gross margin declined 40 basis points to 57.8% year over year GAAP loss per share of $0.15; adjusted earnings per share of $0.01 Launched PATHFINDER I...
AngioDynamics (NASDAQ: ANGO ) is scheduled to announce Q3 earnings results on Tuesday, April 7th, before market open. The consensus EPS Estimate is -$0.03 (-115.8% Y/Y) and the consensus Revenue Estimate is $68.55M (-20.6% Y/Y). Over the last 2 years, ANGO has beaten EPS estimates 50...
New York City, NY:March 26, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Ablation Equipment Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the report is to offer updates and i...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the third quarter of fiscal year 2020 before the market open on Tu...
News, Short Squeeze, Breakout and More Instantly...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that its management is schedule...
Equity Bancshares Inc. Class A (EQBK) is expected to report $0.92 for Q2 2024 Bank of America Corporation (BAC) is expected to report $0.79 for Q2 2024 Aehr Test Systems (AEHR) is expected to report $0.09 for Q4 2024 America Movil S.A.B. de C.V.n Depositary Shares (each representing t...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the fourt...